Physician profile
Michael J Rieser
NPI 1598825358
$1,335.98
in general payments reported to CMS, 2019-2025
11 companies · $120 in 2025
The $120 reported for 2025 was less than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $284 · 2021: $122 · 2022: $166 · 2023: $424 · 2024: $220 · 2025: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $764.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $763.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $288.33 | 2022-2024 | Vraylar |
| Teva Pharmaceuticals USA, INC. | $284.37 | 2019-2024 | Uzedy |
| Otsuka America Pharmaceutical, INC. | $197.35 | 2023-2025 | Rexulti |
| Corium, LLC | $128.17 | 2022-2023 | Azstarys |
| Janssen Pharmaceuticals, INC | $123.26 | 2019 | |
| Axsome Therapeutics, INC. | $119.34 | 2023 | Auvelity |
| Alkermes, INC. | $100.49 | 2021 | |
| Neos Therapeutics, LP | $32.96 | 2022 | |
| Lundbeck LLC | $24.47 | 2019 | |
| Acadia Pharmaceuticals INC | $22.67 | 2022 | |
| Bausch Health US, LLC | $14.57 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Rieser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.